Proceedings of the National Academy of Sciences of the United States of America, Vol. 86, No. 14 (Jul. 15, 1989), pp. 5575-5579 (5 pages) ...

Winning a rare insight into the cause of schizophrenia and possible ways to treat it, scientists in Boston say they have identified a biochemical pathway that contributes to the disease by altering ...

July 31, 2007 (New York, NY)-Serum levels of complement factors C3 and C4 were predictors of stroke risk over two years in a cohort of men referred for coronary angiography, with C4 emerging as ...

Please provide your email address to receive an email when new articles are posted on . Meningococcal vaccination rates are low among eligible patients with complement component deficiencies, ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 69, No. 1 (Jan., 1972), pp. 65-68 (4 pages) The human complement component, Clq, is a fragile molecule of delicate ...

Global understanding of complement has shifted and developed since the 21st century: from our idea of a blood-based antibiotic system to a global regulator of immunity and tissue homeostasis. Recent ...

It was called ‘complement’ because it aided the antibacterial activity of antibodies. However, it is now known that the complement system can be activated early in an infection without the presence of ...

Alnylam Scientists Present Pre-clinical Data with ALN-CC5, an RNAi Therapeutic Targeting Complement Component C5 for the Treatment of Complement-Mediated Diseases – New Research Presented at 6 th ...

CAMBRIDGE, Mass.--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, today announced initial positive results from its ongoing Phase 1/2 clinical trial with ALN-CC5, an ...